FDA Panel Recommends Abbott's Absorb Bioresorbable Vascular Scaffold for Approval

This is the first installment of a two part feature regarding current thinking about the Bioresorbable Vascular Scaffold. Part One discusses the history and some general background issues surrounding the device; Part Two (to be posted later this week) consists of comments from leading interventional cardiologists about the current and future implications, predictions, critiques, and recommendations for the utilization of BVS.
Source: News from Angioplasty.Org - Category: Cardiology Source Type: news